Mesirow Financial Investment Management’s Nephros NEPH Stock Holding History

Mesirow Financial Investment Management’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Sell	60,000 -60,000	-50%	-$195K	﹤0.01%	493
2026 Q1	$358K	Buy	120,000 +70,000	+140%	+$279K	0.01%	399
2025 Q4	$244K	Buy	50,000 +36,200	+262%	+$185K	0.01%	435
2025 Q3	$65.3K	Hold	13,800	–	–	﹤0.01%	546
2025 Q2	$56.4K	Hold	13,800	–	–	﹤0.01%	526
2025 Q1	$23.7K	Hold	13,800	–	–	﹤0.01%	585
2024 Q4	$20.3K	Hold	13,800	–	–	﹤0.01%	589
2024 Q3	$23.6K	Hold	13,800	–	–	﹤0.01%	589
2024 Q2	$29.1K	Sell	13,800 -1,583	-10%	-$3.42K	﹤0.01%	502
2024 Q1	$33.7K	Hold	15,383	–	–	﹤0.01%	514
2023 Q4	$53.2K	Buy	+15,383	New	+$33.5K	﹤0.01%	544

Other funds holding NEPH

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Mesirow Financial Investment Management's NEPH Position: Q2 2026 in Review

Mesirow Financial Investment Management reduced its Nephros (NEPH) stake by 50% in Q2 2026, selling an estimated $195K and leaving 60,000 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Mesirow Financial Investment Management first reported a position in NEPH in Q4 2023 and has held it in 11 quarters since. The position peaked at $358K in Q1 2026. 29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

Mesirow Financial Investment Management held 60,000 shares of Nephros worth $214K as of Q2 2026.
Mesirow Financial Investment Management sold 60,000 Nephros shares in Q2 2026, an estimated $195K.
Nephros made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #493 holding.
Mesirow Financial Investment Management first reported a position in Nephros in Q4 2023 and has held it in 11 quarters since.
Mesirow Financial Investment Management's Nephros position peaked at $358K in Q1 2026.
29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.